Complement System in Pathogenesis of AMD: Dual Player in Degeneration and Protection of Retinal Tissue
暂无分享,去创建一个
D. Rogińska | A. Machalińska | B. Machaliński | M. Kawa | Milosz P. Kawa | Anna Machalinska | Dorota Roginska | Boguslaw Machalinski
[1] Laura A. Hecker,et al. Genetic control of the alternative pathway of complement in humans and age-related macular degeneration. , 2010, Human molecular genetics.
[2] Masaru Miyagi,et al. Drusen proteome analysis: An approach to the etiology of age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Barnum,et al. CNS-specific expression of C3a and C5a exacerbate demyelination severity in the cuprizone model. , 2010, Molecular immunology.
[4] D. Karczewicz,et al. Elevated Plasma Levels of C3a Complement Compound in the Exudative Form of Age-Related Macular Degeneration , 2009, Ophthalmic Research.
[5] S. Rodríguez de Córdoba,et al. Functional basis of protection against age-related macular degeneration conferred by a common polymorphism in complement factor B , 2009, Proceedings of the National Academy of Sciences.
[6] Johanna M Seddon,et al. Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration , 2006, Nature Genetics.
[7] H. Vaudry,et al. Journal of Neuroinflammation Interleukin-1β and Anaphylatoxins Exert a Synergistic Effect on Ngf Expression by Astrocytes , 2006 .
[8] Anand Swaroop,et al. Unraveling a multifactorial late-onset disease: from genetic susceptibility to disease mechanisms for age-related macular degeneration. , 2009, Annual review of genomics and human genetics.
[9] Gabriëlle H S Buitendijk,et al. Seven New Loci Associated with Age-Related Macular Degeneration , 2013, Nature Genetics.
[10] A. Verkerk,et al. Functional annotation of the human retinal pigment epithelium transcriptome , 2009, BMC Genomics.
[11] Martin Oppermann,et al. Systemic Complement Activation in Age-Related Macular Degeneration , 2008, PloS one.
[12] Aaron Y. Lee,et al. Common variants near FRK/COL10A1 and VEGFA are associated with advanced age-related macular degeneration , 2011, Human molecular genetics.
[13] Christine A. Curcio,et al. Abundant Lipid and Protein Components of Drusen , 2010, PloS one.
[14] Johanna M Seddon,et al. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. , 2005, Archives of ophthalmology.
[15] V. Tuohy,et al. IFN-γ and IL-17 Production in Experimental Autoimmune Encephalomyelitis Depends on Local APC–T Cell Complement Production1 , 2008, The Journal of Immunology.
[16] Cathy Frey,et al. Investigative Ophthalmology and Visual Science , 2010 .
[17] Margaret A. Pericak-Vance,et al. Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.
[18] J. Ott,et al. Polymorphisms in C2, CFB and C3 are associated with progression to advanced age related macular degeneration associated with visual loss , 2008, Journal of Medical Genetics.
[19] Hongyu Zhao,et al. Evidence for association between multiple complement pathway genes and AMD , 2007, Genetic epidemiology.
[20] K. Rock,et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization , 2008, Nature Immunology.
[21] B. Morgan,et al. The disease-protective complement factor H allotypic variant Ile62 shows increased binding affinity for C3b and enhanced cofactor activity. , 2009, Human molecular genetics.
[22] M. Dragunow,et al. Complement‐Derived Anaphylatoxin C3a Regulates In Vitro Differentiation and Migration of Neural Progenitor Cells , 2009, Stem cells.
[23] Alexander J. Rivest,et al. The Alzheimer's Aβ-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] B. Morgan,et al. Complement dysregulation and disease: from genes and proteins to diagnostics and drugs. , 2012, Immunobiology.
[25] P. Mukherjee,et al. The role of complement anaphylatoxin C5a in neurodegeneration: implications in Alzheimer’s disease , 2000, Journal of Neuroimmunology.
[26] J. Sparrow,et al. Complement dysregulation in AMD: RPE-Bruch's membrane-choroid. , 2012, Molecular aspects of medicine.
[27] Yang Wang,et al. Genome-wide association identifies SKIV2L and MYRIP as protective factors for age-related macular degeneration , 2010, Genes and Immunity.
[28] C. Dinarello,et al. A new biologic role for C3a and C3a desArg: regulation of TNF-alpha and IL-1 beta synthesis. , 1996, Journal of immunology.
[29] L. V. Johnson,et al. Complement activation and inflammatory processes in Drusen formation and age related macular degeneration. , 2001, Experimental eye research.
[30] M. Gorin. Genetic insights into age-related macular degeneration: controversies addressing risk, causality, and therapeutics. , 2012, Molecular aspects of medicine.
[31] E. Lenassi,et al. Complement component C3 plays a critical role in protecting the aging retina in a murine model of age-related macular degeneration. , 2013, The American journal of pathology.
[32] A. Ramé. [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.
[33] Don H. Anderson,et al. Extended haplotypes in the complement factor H (CFH) and CFH‐related (CFHR) family of genes protect against age‐related macular degeneration: Characterization, ethnic distribution and evolutionary implications , 2006, Annals of medicine.
[34] P. Gasque. Complement: a unique innate immune sensor for danger signals. , 2004, Molecular immunology.
[35] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[36] A. Mathai,et al. The involvement of complement factor B and complement component C2 in an Indian cohort with age-related macular degeneration. , 2010, Investigative ophthalmology & visual science.
[37] J. Haines,et al. Haplotypes spanning the complement factor H gene are protective against age-related macular degeneration. , 2007, Investigative ophthalmology & visual science.
[38] Thomas J. Lukas,et al. The Aged Retinal Pigment Epithelium/Choroid: A Potential Substratum for the Pathogenesis of Age-Related Macular Degeneration , 2008, PloS one.
[39] Alexander J. Rivest,et al. Characterization of β amyloid assemblies in drusen: The deposits associated with aging and age-related macular degeneration , 2004 .
[40] A. Edwards,et al. Molecular genetics of AMD and current animal models , 2007, Angiogenesis.
[41] M. Pekny,et al. Complement: a novel factor in basal and ischemia‐induced neurogenesis , 2006, The EMBO journal.
[42] Don H. Anderson,et al. The pivotal role of the complement system in aging and age-related macular degeneration: Hypothesis re-visited , 2010, Progress in retinal and eye research.
[43] S. Kase,et al. Regulated secretion of complement factor H by RPE and its role in RPE migration , 2009, Graefe's Archive for Clinical and Experimental Ophthalmology.
[44] Don H. Anderson,et al. Extended haplotypes in the complement factor H (CFH) and CFH-related (CFHR) family of genes protect against age-related macular degeneration: characterization, ethnic distribution and evolutionary implications. , 2006, Annals of medicine.
[45] S. Cashman,et al. Expression of complement component 3 (C3) from an adenovirus leads to pathology in the murine retina. , 2011, Investigative ophthalmology & visual science.
[46] A. Joussen,et al. Enhanced expression of the complement factor H mRNA in proliferating human RPE cells , 2010, Graefe's Archive for Clinical and Experimental Ophthalmology.
[47] S. Ingersoll,et al. Transcriptional control of the C3a receptor gene in glial cells: Dependence upon AP-1 but not Ets. , 2007, Molecular immunology.
[48] R. Guymer,et al. Analysis of rare variants in the complement component 2 (C2) and factor B (BF) genes refine association for age-related macular degeneration (AMD). , 2009, Investigative ophthalmology & visual science.
[49] Marco A Zarbin,et al. Current concepts in the pathogenesis of age-related macular degeneration. , 2004, Archives of ophthalmology.
[50] H. Rus,et al. Sublytic complement attack induces cell cycle in oligodendrocytes. , 1996, Journal of immunology.
[51] T. Woodruff,et al. Dendritic Cell Function in Allostimulation Is Modulated by C5aR Signaling1 , 2009, The Journal of Immunology.
[52] P. Mukherjee,et al. Complement anaphylatoxin C5a neuroprotects through regulation of glutamate receptor subunit 2 in vitro and in vivo , 2008, Journal of Neuroinflammation.
[53] T. Becker,et al. CFH, C3 and ARMS2 Are Significant Risk Loci for Susceptibility but Not for Disease Progression of Geographic Atrophy Due to AMD , 2009, PloS one.
[54] J. Forrester,et al. Up-regulation of complement factor B in retinal pigment epithelial cells is accompanied by complement activation in the aged retina. , 2008, Experimental eye research.
[55] C. Curcio,et al. Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy. , 2003, The American journal of pathology.
[56] P.T.V.M. de Jong,et al. Mechanisms of disease: Age-related macular degeneration , 2006 .
[57] P. Gasque,et al. Activation of Complement in the Central Nervous System , 2003, Annals of the New York Academy of Sciences.
[58] C. Lemere,et al. Complement C3 Deficiency Leads to Accelerated Amyloid β Plaque Deposition and Neurodegeneration and Modulation of the Microglia/Macrophage Phenotype in Amyloid Precursor Protein Transgenic Mice , 2008, The Journal of Neuroscience.
[59] Sivakumar Gowrisankar,et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration , 2011, Nature Genetics.
[60] Purushottam Jha,et al. Role of complement and complement membrane attack complex in laser-induced choroidal neovascularization. , 2005, Journal of immunology.
[61] J. Attia,et al. Human Genome Epidemiology (HuGE) Review Systematic Review and Meta-Analysis of the Association Between Complement Component 3 and Age-related Macular Degeneration: A HuGE Review and Meta- Analysis , 2011 .
[62] D. Friedman,et al. Prevalence of decreased visual acuity among preschool-aged children in an American urban population: the Baltimore Pediatric Eye Disease Study, methods, and results. , 2008, Ophthalmology.
[63] G. Maurer,et al. The complement component C5a induces the expression of plasminogen activator inhibitor‐1 in human macrophages via NF‐κB activation , 2006, Journal of thrombosis and haemostasis : JTH.
[64] R. Tompkins,et al. Both C3a and C3a(desArg) regulate interleukin-6 synthesis in human peripheral blood mononuclear cells. , 1998, The Journal of infectious diseases.
[65] J. Forrester,et al. Synthesis of complement factor H by retinal pigment epithelial cells is down-regulated by oxidized photoreceptor outer segments. , 2007, Experimental eye research.
[66] G. Dubyak,et al. Locally produced complement fragments C5a and C3a provide both costimulatory and survival signals to naive CD4+ T cells. , 2008, Immunity.
[67] J. Ordovás,et al. Evaluation of new and established age-related macular degeneration susceptibility genes in the Women's Health Initiative Sight Exam (WHI-SE) Study. , 2011, American journal of ophthalmology.
[68] D. Bok,et al. Cell culture model that mimics drusen formation and triggers complement activation associated with age-related macular degeneration , 2011, Proceedings of the National Academy of Sciences.
[69] E. Mackenzie,et al. Complement anaphylatoxin C3a is selectively protective against NMDA-induced neuronal cell death , 2001, Neuroreport.
[70] P. Bora,et al. Role of ocular complement factor H in a murine model of choroidal neovascularization. , 2010, The American journal of pathology.
[71] H. Kaplan,et al. Complement Activation via Alternative Pathway Is Critical in the Development of Laser-Induced Choroidal Neovascularization: Role of Factor B and Factor H1 , 2006, The Journal of Immunology.
[72] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[73] M. Daly,et al. Variation near complement factor I is associated with risk of advanced AMD , 2009, European Journal of Human Genetics.
[74] U. Schlötzer-Schrehardt,et al. Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. , 2009, Blood.
[75] A. Tenner,et al. Complement component C1q inhibits β‐amyloid‐ and serum amyloid P‐induced neurotoxicity via caspase‐ and calpain‐independent mechanisms , 2007, Journal of neurochemistry.
[76] J. Haines,et al. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. , 2007, Human molecular genetics.
[77] S. Hagstrom,et al. Genetic analysis of complement factor H related 5, CFHR5, in patients with age-related macular degeneration , 2009, Molecular vision.
[78] S. Russell,et al. Drusen associated with aging and age‐related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[79] Y. Hathout,et al. Identification of novel substrates for the serine protease HTRA1 in the human RPE secretome. , 2010, Investigative ophthalmology & visual science.
[80] J. Halperin,et al. Terminal complement proteins C5b-9 release basic fibroblast growth factor and platelet-derived growth factor from endothelial cells , 1994, The Journal of experimental medicine.
[81] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[82] R. Hogg,et al. Further assessment of the complement component 2 and factor B region associated with age-related macular degeneration. , 2009, Investigative ophthalmology & visual science.
[83] John D Lambris,et al. Drusen complement components C3a and C5a promote choroidal neovascularization. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[84] P. Bora,et al. CD59, a Complement Regulatory Protein, Controls Choroidal Neovascularization in a Mouse Model of Wet-Type Age-Related Macular Degeneration1 , 2007, The Journal of Immunology.
[85] M. Pangburn,et al. Oxidative Stress Renders Retinal Pigment Epithelial Cells Susceptible to Complement-mediated Injury* , 2009, The Journal of Biological Chemistry.
[86] P. Ward. Functions of C5a receptors , 2009, Journal of Molecular Medicine.
[87] C. Curcio,et al. Basal deposits and drusen in eyes with age-related maculopathy: evidence for solid lipid particles. , 2005, Experimental eye research.
[88] John D Lambris,et al. Complement: a key system for immune surveillance and homeostasis , 2010, Nature Immunology.
[89] L. Soane,et al. Sublytic C5b‐9‐stimulated Schwann cell survival through PI 3‐kinase‐mediated phosphorylation of BAD , 2001, Glia.
[90] H. Rus,et al. Inhibition of oligodendrocyte apoptosis by sublytic C5b-9 is associated with enhanced synthesis of bcl-2 and mediated by inhibition of caspase-3 activation. , 1999, Journal of immunology.
[91] Benita J. O’Colmain,et al. Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.
[92] Ian C. Han,et al. Expression and modulation of RPE cell membrane complement regulatory proteins. , 2009, Investigative ophthalmology & visual science.
[93] A. Tenner,et al. Complement Protein C1q-Mediated Neuroprotection Is Correlated with Regulation of Neuronal Gene and MicroRNA Expression , 2011, The Journal of Neuroscience.
[94] R. Klein,et al. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. , 1997, Ophthalmology.
[95] C. Curcio,et al. Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. , 2005, Investigative ophthalmology & visual science.
[96] B. Rosner,et al. Plasma complement components and activation fragments: associations with age-related macular degeneration genotypes and phenotypes. , 2009, Investigative ophthalmology & visual science.
[97] J. Hollyfield,et al. NLRP3 has a protective role in age-related macular degeneration through the induction of IL-18 by drusen components , 2012, Nature Medicine.
[98] P. Jong. Prevalence of age-related macular degeneration in the United States. , 2004 .
[99] I. Bhutto,et al. Understanding age-related macular degeneration (AMD): relationships between the photoreceptor/retinal pigment epithelium/Bruch's membrane/choriocapillaris complex. , 2012, Molecular aspects of medicine.
[100] Ronald Klein,et al. A simplified severity scale for age-related macular degeneration: AREDS Report No. 18. , 2005, Archives of ophthalmology.
[101] N. Peachey,et al. A novel role of complement in retinal degeneration. , 2011, Investigative ophthalmology & visual science.
[102] L. V. Johnson,et al. A potential role for immune complex pathogenesis in drusen formation. , 2000, Experimental eye research.
[103] Robert F Mullins,et al. A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.
[104] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[105] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[106] D. Fearon,et al. Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease risk , 2011, Proceedings of the National Academy of Sciences.
[107] R. Medzhitov. Origin and physiological roles of inflammation , 2008, Nature.
[108] C. Janeway,et al. The complement system and innate immunity , 2001 .
[109] D. Weeks,et al. C2 and CFB Genes in Age-Related Maculopathy and Joint Action with CFH and LOC387715 Genes , 2008, PloS one.
[110] A. Mizota,et al. Complement factor H polymorphisms in Japanese population with age-related macular degeneration. , 2006, Molecular vision.
[111] N. Orr,et al. A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration , 2006, Nature Genetics.
[112] J. Lambris,et al. C3a Is Required for the Production of CXC Chemokines by Tubular Epithelial Cells after Renal Ishemia/Reperfusion1 , 2007, The Journal of Immunology.
[113] P. Aisen,et al. Complement‐derived anaphylatoxin C5a protects against glutamate‐mediated neurotoxicity , 1999, Journal of cellular biochemistry.
[114] Klaus Heese,et al. Inflammatory Signals Induce Neurotrophin Expression in Human Microglial Cells , 1998, Journal of neurochemistry.
[115] C. Keilhauer,et al. An imbalance of human complement regulatory proteins CFHR1, CFHR3 and factor H influences risk for age-related macular degeneration (AMD). , 2010, Human molecular genetics.